FLT3 and acute myeloid leukemia: constructed a novel prognostic scoring model for newly diagnosed FLT3-ITD-positive AML (23), but the model has some limitations such as induction and consolidation treatment regimens cannot be fully harmonized due to the retrospective nature of the study.